<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT20251229068482N1</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2026-02-16</date_registration>
      <primary_sponsor>Shiraz University of Medical Sciences</primary_sponsor>
      <public_title>The Effects of logo therapy on the cancer patients’ caregivers</public_title>
      <acronym></acronym>
      <scientific_title>Studying the Effectiveness of Group Logotherapy on the Care Burden and Quality of life of Cancer Patients’ Caregivers</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2026-01-15</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>60</target_size>
      <recruitment_status>Complete</recruitment_status>
      <url>https://irct.ir/trial/88410</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: Randomized, Blinding: Single blinded, Placebo: Not used, Assignment: Parallel, Purpose: Supportive, Randomization description: In this study, after confirming eligibility criteria and obtaining written informed consent, participants were allocated to the intervention and control groups using simple randomization with a 1:1 allocation ratio. The unit of randomization was the individual, and neither cluster randomization nor stratified randomization was applied.
The random allocation sequence was generated prior to participant recruitment by an independent researcher using a random numbers table. Group assignment was determined based on whether the generated numbers were odd or even, and a complete allocation list was prepared in advance. This researcher was not involved in participant recruitment or intervention implementation.
To ensure allocation concealment, the prepared random sequence was placed in sequentially numbered, opaque, sealed, and impermeable envelopes. The envelopes were opened in order of participants’ entry into the study, ensuring that group assignment was not predictable for either the researcher or the participants prior to allocation, Blinding description: Due to the nature of the intervention, which involved group logotherapy, blinding of participants and health care providers delivering the intervention was not feasible. Participants were aware of whether they received the intervention, and the therapist was directly involved in delivering the sessions. The principal investigator was also aware of group allocation because of involvement in the design and implementation of the study.

To minimize potential bias in outcome assessment, the outcome assessor responsible for collecting questionnaires and evaluating outcome variables was kept blinded to group allocation. Data were provided to the assessor without any indication of the participants’ group assignment.

Data analysis was performed after completion of data collection, and the data analyst was aware of the original group allocation. Given the academic nature and limited scale of the study, no Data Safety and Monitoring Committee was established. All participants provided written informed consent after receiving complete information about the study objectives and procedures.</study_design>
      <phase>N/A</phase>
      <hc_freetext>Cancer.</hc_freetext>
      <i_freetext>Intervention 1: Intervention Group:Participants in this group receive group logotherapy through a structured 8-session weekly program, each session lasting 90 minutes, based on Viktor Frankl’s logotherapy principles. Session content includes:Introduction to logotherapy conceptsIdentifying personal values and sources of meaningReviewing caregiving burden and attitude toward sufferingTransforming suffering into growth opportunitiesEnhancing hope and psychological resilienceClarifying caregiving roleIntegrating meaning into daily lifeAll sessions are conducted by a trained therapist, and participants receive identical content throughout the intervention period.Control Group:Participants in this group receive no structured logotherapy intervention and continue with routine care and standard clinic services. Intervention 2: Control group: Participants in the control group will not receive any group logotherapy intervention during the study period and will receive only the usual care and services routinely provided at Shahid Motahari Clinic. No additional educational or psychological intervention will be provided to this group during the study period.</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan>No - There is not a plan to make this available</results_IPD_plan>
      <results_IPD_description>Justification or reason for not sharing IPD is There is no plan to share individual participant data from this study. No further information is available.</results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>Mohammad Hadi Owjfard</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>No 21, Rezvan residential complex, North Motahari Blvd, Shiraz</address>
        <city>Shiraz</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>7186899517</zip>
        <telephone>+98 71 3620 3478</telephone>
        <email>mhadiog@gmail.com</email>
        <affiliation>Shiraz University of Medical Sciences</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>Shahrzad YektaTalab</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Fatemeh School of Nursing and Midwifery, Entrance to Namazee Hospital, Namazee Square, Shiraz, Iran</address>
        <city>Shiraz</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>7193613119</zip>
        <telephone>+98 71 3647 4252</telephone>
        <email>shahrzadyekta@yahoo.com</email>
        <affiliation>Shiraz University of Medical Sciences</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Iran (Islamic Republic of)</country2>
    </countries>
    <criteria>
      <inclusion_criteria>Voluntary Willingness to Participate in the Study and Signing the Informed Consent Form
Membership in the Patient’s Family and Direct Responsibility for Daily Care
A Minimum History of Three Months of Direct Caregiving With an Average of at Least Two Hours per Day for a Patient With Cancer (Based on Self-Report in the Demographic Form)
Aged eighteen years or older.
No Receipt of Payment or Salary for Caregiving
Ability to Read and Write in the Persian Language
No History of Severe Psychiatric Disorders or Cognitive Impairment Based on Self-Report or Medical Records</inclusion_criteria>
      <agemin>18 years</agemin>
      <agemax>no limit</agemax>
      <gender>Both</gender>
      <exclusion_criteria>History of substance abuse or current use of psychoactive medications at the time of study entry.
Inability to plan for attendance at group logotherapy sessions at the time of study entry.</exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code>C00-C97</hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword>Malignant neoplasms</hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>Behavior</i_code>
      <i_code>Behavior</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>Intervention Group:Participants in this group receive group logotherapy through a structured 8-session weekly program, each session lasting 90 minutes, based on Viktor Frankl’s logotherapy principles. Session content includes:Introduction to logotherapy conceptsIdentifying personal values and sources of meaningReviewing caregiving burden and attitude toward sufferingTransforming suffering into growth opportunitiesEnhancing hope and psychological resilienceClarifying caregiving roleIntegrating meaning into daily lifeAll sessions are conducted by a trained therapist, and participants receive identical content throughout the intervention period.Control Group:Participants in this group receive no structured logotherapy intervention and continue with routine care and standard clinic services.</i_keyword>
      <i_keyword>Control group: Participants in the control group will not receive any group logotherapy intervention during the study period and will receive only the usual care and services routinely provided at Shahid Motahari Clinic. No additional educational or psychological intervention will be provided to this group during the study period.</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>Caregiving burden score among caregivers of patients with cancer measured using the Zarit Burden Interview. Timepoint: Caregiving burden will be measured at two time points; at baseline before the start of the group logotherapy intervention; and at the end of the intervention period immediately after completion of the group logotherapy sessions. Method of measurement: Caregiving burden among caregivers of patients with cancer will be measured using the Zarit Burden Interview questionnaire.</prim_outcome>
      <prim_outcome>Quality of life score among caregivers of patients with cancer measured using the World Health Organization Quality of Life Brief questionnaire. Timepoint: Quality of life will be measured at two time points; at baseline before the start of the group logotherapy intervention; and at the end of the intervention period immediately after completion of all group logotherapy sessions. Method of measurement: Quality of life among caregivers of patients with cancer will be measured using the World Health Organization Quality of Life Brief questionnaire.</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome></sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>Shiraz University of Medical Sciences</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2025-11-01</approval_date>
        <contact_name>Ethics Committee of the Schools of Nursing and Midwifery, Management &amp; Medical Information Sciences</contact_name>
        <contact_address>Seventh Floor, Central Building, Shiraz University of Medical Sciences, Adjacent to the Red Crescent, Zand Street, Shiraz, Iran Shiraz Fars Iran (Islamic Republic of)</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
